1 Study Coverage
    1.1 Antiviral Drugs Product Introduction
    1.2 Market by Type
        1.2.1 Global Antiviral Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Reverse Transcriptase Inhibitors
        1.2.3 Protease Inhibitors
        1.2.4 Fusion Inhibitors
        1.2.5 Immune System Modulators
    1.3 Market by Application
        1.3.1 Global Antiviral Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hepatitis Therapeutics
        1.3.3 HIV/AIDS Therapeutics
        1.3.4 Herpes Therapeutics
        1.3.5 Influenza Therapeutics
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Antiviral Drugs Sales Estimates and Forecasts 2017-2028
    2.2 Global Antiviral Drugs Revenue Estimates and Forecasts 2017-2028
    2.3 Global Antiviral Drugs Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Antiviral Drugs Sales by Region
        2.4.1 Global Antiviral Drugs Sales by Region (2017-2022)
        2.4.2 Global Sales Antiviral Drugs by Region (2023-2028)
    2.5 Global Antiviral Drugs Revenue by Region
        2.5.1 Global Antiviral Drugs Revenue by Region (2017-2022)
        2.5.2 Global Antiviral Drugs Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Antiviral Drugs Sales by Manufacturers
        3.1.1 Global Top Antiviral Drugs Manufacturers by Sales (2017-2022)
        3.1.2 Global Antiviral Drugs Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Antiviral Drugs in 2021
    3.2 Global Antiviral Drugs Revenue by Manufacturers
        3.2.1 Global Antiviral Drugs Revenue by Manufacturers (2017-2022)
        3.2.2 Global Antiviral Drugs Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Antiviral Drugs Revenue in 2021
    3.3 Global Antiviral Drugs Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Antiviral Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Antiviral Drugs Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Antiviral Drugs Sales by Type
        4.1.1 Global Antiviral Drugs Historical Sales by Type (2017-2022)
        4.1.2 Global Antiviral Drugs Forecasted Sales by Type (2023-2028)
        4.1.3 Global Antiviral Drugs Sales Market Share by Type (2017-2028)
    4.2 Global Antiviral Drugs Revenue by Type
        4.2.1 Global Antiviral Drugs Historical Revenue by Type (2017-2022)
        4.2.2 Global Antiviral Drugs Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Antiviral Drugs Revenue Market Share by Type (2017-2028)
    4.3 Global Antiviral Drugs Price by Type
        4.3.1 Global Antiviral Drugs Price by Type (2017-2022)
        4.3.2 Global Antiviral Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Antiviral Drugs Sales by Application
        5.1.1 Global Antiviral Drugs Historical Sales by Application (2017-2022)
        5.1.2 Global Antiviral Drugs Forecasted Sales by Application (2023-2028)
        5.1.3 Global Antiviral Drugs Sales Market Share by Application (2017-2028)
    5.2 Global Antiviral Drugs Revenue by Application
        5.2.1 Global Antiviral Drugs Historical Revenue by Application (2017-2022)
        5.2.2 Global Antiviral Drugs Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Antiviral Drugs Revenue Market Share by Application (2017-2028)
    5.3 Global Antiviral Drugs Price by Application
        5.3.1 Global Antiviral Drugs Price by Application (2017-2022)
        5.3.2 Global Antiviral Drugs Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Antiviral Drugs Market Size by Type
        6.1.1 North America Antiviral Drugs Sales by Type (2017-2028)
        6.1.2 North America Antiviral Drugs Revenue by Type (2017-2028)
    6.2 North America Antiviral Drugs Market Size by Application
        6.2.1 North America Antiviral Drugs Sales by Application (2017-2028)
        6.2.2 North America Antiviral Drugs Revenue by Application (2017-2028)
    6.3 North America Antiviral Drugs Market Size by Country
        6.3.1 North America Antiviral Drugs Sales by Country (2017-2028)
        6.3.2 North America Antiviral Drugs Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Antiviral Drugs Market Size by Type
        7.1.1 Europe Antiviral Drugs Sales by Type (2017-2028)
        7.1.2 Europe Antiviral Drugs Revenue by Type (2017-2028)
    7.2 Europe Antiviral Drugs Market Size by Application
        7.2.1 Europe Antiviral Drugs Sales by Application (2017-2028)
        7.2.2 Europe Antiviral Drugs Revenue by Application (2017-2028)
    7.3 Europe Antiviral Drugs Market Size by Country
        7.3.1 Europe Antiviral Drugs Sales by Country (2017-2028)
        7.3.2 Europe Antiviral Drugs Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Antiviral Drugs Market Size by Type
        8.1.1 Asia Pacific Antiviral Drugs Sales by Type (2017-2028)
        8.1.2 Asia Pacific Antiviral Drugs Revenue by Type (2017-2028)
    8.2 Asia Pacific Antiviral Drugs Market Size by Application
        8.2.1 Asia Pacific Antiviral Drugs Sales by Application (2017-2028)
        8.2.2 Asia Pacific Antiviral Drugs Revenue by Application (2017-2028)
    8.3 Asia Pacific Antiviral Drugs Market Size by Region
        8.3.1 Asia Pacific Antiviral Drugs Sales by Region (2017-2028)
        8.3.2 Asia Pacific Antiviral Drugs Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Antiviral Drugs Market Size by Type
        9.1.1 Latin America Antiviral Drugs Sales by Type (2017-2028)
        9.1.2 Latin America Antiviral Drugs Revenue by Type (2017-2028)
    9.2 Latin America Antiviral Drugs Market Size by Application
        9.2.1 Latin America Antiviral Drugs Sales by Application (2017-2028)
        9.2.2 Latin America Antiviral Drugs Revenue by Application (2017-2028)
    9.3 Latin America Antiviral Drugs Market Size by Country
        9.3.1 Latin America Antiviral Drugs Sales by Country (2017-2028)
        9.3.2 Latin America Antiviral Drugs Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Antiviral Drugs Market Size by Type
        10.1.1 Middle East and Africa Antiviral Drugs Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Antiviral Drugs Revenue by Type (2017-2028)
    10.2 Middle East and Africa Antiviral Drugs Market Size by Application
        10.2.1 Middle East and Africa Antiviral Drugs Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Antiviral Drugs Revenue by Application (2017-2028)
    10.3 Middle East and Africa Antiviral Drugs Market Size by Country
        10.3.1 Middle East and Africa Antiviral Drugs Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Antiviral Drugs Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Roche
        11.1.1 Roche Corporation Information
        11.1.2 Roche Overview
        11.1.3 Roche Antiviral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Roche Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Roche Recent Developments
    11.2 Johnson & Johnson
        11.2.1 Johnson & Johnson Corporation Information
        11.2.2 Johnson & Johnson Overview
        11.2.3 Johnson & Johnson Antiviral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Johnson & Johnson Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Johnson & Johnson Recent Developments
    11.3 Merck
        11.3.1 Merck Corporation Information
        11.3.2 Merck Overview
        11.3.3 Merck Antiviral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Merck Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Merck Recent Developments
    11.4 Novartis
        11.4.1 Novartis Corporation Information
        11.4.2 Novartis Overview
        11.4.3 Novartis Antiviral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Novartis Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Novartis Recent Developments
    11.5 Bristol-Myers Squibb
        11.5.1 Bristol-Myers Squibb Corporation Information
        11.5.2 Bristol-Myers Squibb Overview
        11.5.3 Bristol-Myers Squibb Antiviral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Bristol-Myers Squibb Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Bristol-Myers Squibb Recent Developments
    11.6 Gilead Sciences
        11.6.1 Gilead Sciences Corporation Information
        11.6.2 Gilead Sciences Overview
        11.6.3 Gilead Sciences Antiviral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Gilead Sciences Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Gilead Sciences Recent Developments
    11.7 GlaxoSmithKline
        11.7.1 GlaxoSmithKline Corporation Information
        11.7.2 GlaxoSmithKline Overview
        11.7.3 GlaxoSmithKline Antiviral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 GlaxoSmithKline Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 GlaxoSmithKline Recent Developments
    11.8 AbbVie
        11.8.1 AbbVie Corporation Information
        11.8.2 AbbVie Overview
        11.8.3 AbbVie Antiviral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 AbbVie Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 AbbVie Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Antiviral Drugs Industry Chain Analysis
    12.2 Antiviral Drugs Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Antiviral Drugs Production Mode & Process
    12.4 Antiviral Drugs Sales and Marketing
        12.4.1 Antiviral Drugs Sales Channels
        12.4.2 Antiviral Drugs Distributors
    12.5 Antiviral Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Antiviral Drugs Industry Trends
    13.2 Antiviral Drugs Market Drivers
    13.3 Antiviral Drugs Market Challenges
    13.4 Antiviral Drugs Market Restraints
14 Key Findings in The Global Antiviral Drugs Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Antiviral Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Reverse Transcriptase Inhibitors
    Table 3. Major Manufacturers of Protease Inhibitors
    Table 4. Major Manufacturers of Fusion Inhibitors
    Table 5. Major Manufacturers of Immune System Modulators
    Table 6. Global Antiviral Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Antiviral Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Antiviral Drugs Sales by Region (2017-2022) & (K Units)
    Table 9. Global Antiviral Drugs Sales Market Share by Region (2017-2022)
    Table 10. Global Antiviral Drugs Sales by Region (2023-2028) & (K Units)
    Table 11. Global Antiviral Drugs Sales Market Share by Region (2023-2028)
    Table 12. Global Antiviral Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 13. Global Antiviral Drugs Revenue Market Share by Region (2017-2022)
    Table 14. Global Antiviral Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 15. Global Antiviral Drugs Revenue Market Share by Region (2023-2028)
    Table 16. Global Antiviral Drugs Sales by Manufacturers (2017-2022) & (K Units)
    Table 17. Global Antiviral Drugs Sales Share by Manufacturers (2017-2022)
    Table 18. Global Antiviral Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 19. Global Antiviral Drugs Revenue Share by Manufacturers (2017-2022)
    Table 20. Antiviral Drugs Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 21. Global Antiviral Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Antiviral Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiviral Drugs as of 2021)
    Table 23. Antiviral Drugs Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Antiviral Drugs Product Offered
    Table 25. Date of Manufacturers Enter into Antiviral Drugs Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Antiviral Drugs Sales by Type (2017-2022) & (K Units)
    Table 28. Global Antiviral Drugs Sales by Type (2023-2028) & (K Units)
    Table 29. Global Antiviral Drugs Sales Share by Type (2017-2022)
    Table 30. Global Antiviral Drugs Sales Share by Type (2023-2028)
    Table 31. Global Antiviral Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 32. Global Antiviral Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 33. Global Antiviral Drugs Revenue Share by Type (2017-2022)
    Table 34. Global Antiviral Drugs Revenue Share by Type (2023-2028)
    Table 35. Antiviral Drugs Price by Type (2017-2022) & (USD/Unit)
    Table 36. Global Antiviral Drugs Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 37. Global Antiviral Drugs Sales by Application (2017-2022) & (K Units)
    Table 38. Global Antiviral Drugs Sales by Application (2023-2028) & (K Units)
    Table 39. Global Antiviral Drugs Sales Share by Application (2017-2022)
    Table 40. Global Antiviral Drugs Sales Share by Application (2023-2028)
    Table 41. Global Antiviral Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 42. Global Antiviral Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 43. Global Antiviral Drugs Revenue Share by Application (2017-2022)
    Table 44. Global Antiviral Drugs Revenue Share by Application (2023-2028)
    Table 45. Antiviral Drugs Price by Application (2017-2022) & (USD/Unit)
    Table 46. Global Antiviral Drugs Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 47. North America Antiviral Drugs Sales by Type (2017-2022) & (K Units)
    Table 48. North America Antiviral Drugs Sales by Type (2023-2028) & (K Units)
    Table 49. North America Antiviral Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 50. North America Antiviral Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 51. North America Antiviral Drugs Sales by Application (2017-2022) & (K Units)
    Table 52. North America Antiviral Drugs Sales by Application (2023-2028) & (K Units)
    Table 53. North America Antiviral Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 54. North America Antiviral Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 55. North America Antiviral Drugs Sales by Country (2017-2022) & (K Units)
    Table 56. North America Antiviral Drugs Sales by Country (2023-2028) & (K Units)
    Table 57. North America Antiviral Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 58. North America Antiviral Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 59. Europe Antiviral Drugs Sales by Type (2017-2022) & (K Units)
    Table 60. Europe Antiviral Drugs Sales by Type (2023-2028) & (K Units)
    Table 61. Europe Antiviral Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 62. Europe Antiviral Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 63. Europe Antiviral Drugs Sales by Application (2017-2022) & (K Units)
    Table 64. Europe Antiviral Drugs Sales by Application (2023-2028) & (K Units)
    Table 65. Europe Antiviral Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 66. Europe Antiviral Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 67. Europe Antiviral Drugs Sales by Country (2017-2022) & (K Units)
    Table 68. Europe Antiviral Drugs Sales by Country (2023-2028) & (K Units)
    Table 69. Europe Antiviral Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 70. Europe Antiviral Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 71. Asia Pacific Antiviral Drugs Sales by Type (2017-2022) & (K Units)
    Table 72. Asia Pacific Antiviral Drugs Sales by Type (2023-2028) & (K Units)
    Table 73. Asia Pacific Antiviral Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 74. Asia Pacific Antiviral Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 75. Asia Pacific Antiviral Drugs Sales by Application (2017-2022) & (K Units)
    Table 76. Asia Pacific Antiviral Drugs Sales by Application (2023-2028) & (K Units)
    Table 77. Asia Pacific Antiviral Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 78. Asia Pacific Antiviral Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 79. Asia Pacific Antiviral Drugs Sales by Region (2017-2022) & (K Units)
    Table 80. Asia Pacific Antiviral Drugs Sales by Region (2023-2028) & (K Units)
    Table 81. Asia Pacific Antiviral Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 82. Asia Pacific Antiviral Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 83. Latin America Antiviral Drugs Sales by Type (2017-2022) & (K Units)
    Table 84. Latin America Antiviral Drugs Sales by Type (2023-2028) & (K Units)
    Table 85. Latin America Antiviral Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 86. Latin America Antiviral Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 87. Latin America Antiviral Drugs Sales by Application (2017-2022) & (K Units)
    Table 88. Latin America Antiviral Drugs Sales by Application (2023-2028) & (K Units)
    Table 89. Latin America Antiviral Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 90. Latin America Antiviral Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 91. Latin America Antiviral Drugs Sales by Country (2017-2022) & (K Units)
    Table 92. Latin America Antiviral Drugs Sales by Country (2023-2028) & (K Units)
    Table 93. Latin America Antiviral Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 94. Latin America Antiviral Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 95. Middle East and Africa Antiviral Drugs Sales by Type (2017-2022) & (K Units)
    Table 96. Middle East and Africa Antiviral Drugs Sales by Type (2023-2028) & (K Units)
    Table 97. Middle East and Africa Antiviral Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 98. Middle East and Africa Antiviral Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 99. Middle East and Africa Antiviral Drugs Sales by Application (2017-2022) & (K Units)
    Table 100. Middle East and Africa Antiviral Drugs Sales by Application (2023-2028) & (K Units)
    Table 101. Middle East and Africa Antiviral Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Middle East and Africa Antiviral Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa Antiviral Drugs Sales by Country (2017-2022) & (K Units)
    Table 104. Middle East and Africa Antiviral Drugs Sales by Country (2023-2028) & (K Units)
    Table 105. Middle East and Africa Antiviral Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa Antiviral Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 107. Roche Corporation Information
    Table 108. Roche Description and Major Businesses
    Table 109. Roche Antiviral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 110. Roche Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Roche Recent Developments
    Table 112. Johnson & Johnson Corporation Information
    Table 113. Johnson & Johnson Description and Major Businesses
    Table 114. Johnson & Johnson Antiviral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 115. Johnson & Johnson Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Johnson & Johnson Recent Developments
    Table 117. Merck Corporation Information
    Table 118. Merck Description and Major Businesses
    Table 119. Merck Antiviral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 120. Merck Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Merck Recent Developments
    Table 122. Novartis Corporation Information
    Table 123. Novartis Description and Major Businesses
    Table 124. Novartis Antiviral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 125. Novartis Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Novartis Recent Developments
    Table 127. Bristol-Myers Squibb Corporation Information
    Table 128. Bristol-Myers Squibb Description and Major Businesses
    Table 129. Bristol-Myers Squibb Antiviral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 130. Bristol-Myers Squibb Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Bristol-Myers Squibb Recent Developments
    Table 132. Gilead Sciences Corporation Information
    Table 133. Gilead Sciences Description and Major Businesses
    Table 134. Gilead Sciences Antiviral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 135. Gilead Sciences Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Gilead Sciences Recent Developments
    Table 137. GlaxoSmithKline Corporation Information
    Table 138. GlaxoSmithKline Description and Major Businesses
    Table 139. GlaxoSmithKline Antiviral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 140. GlaxoSmithKline Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. GlaxoSmithKline Recent Developments
    Table 142. AbbVie Corporation Information
    Table 143. AbbVie Description and Major Businesses
    Table 144. AbbVie Antiviral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 145. AbbVie Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. AbbVie Recent Developments
    Table 147. Key Raw Materials Lists
    Table 148. Raw Materials Key Suppliers Lists
    Table 149. Antiviral Drugs Distributors List
    Table 150. Antiviral Drugs Customers List
    Table 151. Antiviral Drugs Market Trends
    Table 152. Antiviral Drugs Market Drivers
    Table 153. Antiviral Drugs Market Challenges
    Table 154. Antiviral Drugs Market Restraints
    Table 155. Research Programs/Design for This Report
    Table 156. Key Data Information from Secondary Sources
    Table 157. Key Data Information from Primary Sources
List of Figures
    Figure 1. Antiviral Drugs Product Picture
    Figure 3. Global Antiviral Drugs Market Share by Type in 2021 & 2028
    Figure 3. Reverse Transcriptase Inhibitors Product Picture
    Figure 4. Protease Inhibitors Product Picture
    Figure 5. Fusion Inhibitors Product Picture
    Figure 6. Immune System Modulators Product Picture
    Figure 7. Global Antiviral Drugs Market Share by Application in 2021 & 2028
    Figure 8. Hepatitis Therapeutics
    Figure 9. HIV/AIDS Therapeutics
    Figure 10. Herpes Therapeutics
    Figure 11. Influenza Therapeutics
    Figure 12. Antiviral Drugs Report Years Considered
    Figure 13. Global Antiviral Drugs Sales 2017-2028 (K Units)
    Figure 14. Global Antiviral Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Antiviral Drugs Revenue 2017-2028 (US$ Million)
    Figure 16. Global Antiviral Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 17. Global Antiviral Drugs Sales Market Share by Region (2017-2022)
    Figure 18. Global Antiviral Drugs Sales Market Share by Region (2023-2028)
    Figure 19. North America Antiviral Drugs Sales YoY (2017-2028) & (K Units)
    Figure 20. North America Antiviral Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Europe Antiviral Drugs Sales YoY (2017-2028) & (K Units)
    Figure 22. Europe Antiviral Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Asia-Pacific Antiviral Drugs Sales YoY (2017-2028) & (K Units)
    Figure 24. Asia-Pacific Antiviral Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Latin America Antiviral Drugs Sales YoY (2017-2028) & (K Units)
    Figure 26. Latin America Antiviral Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Middle East & Africa Antiviral Drugs Sales YoY (2017-2028) & (K Units)
    Figure 28. Middle East & Africa Antiviral Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. The Antiviral Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 30. The Top 5 and 10 Largest Manufacturers of Antiviral Drugs in the World: Market Share by Antiviral Drugs Revenue in 2021
    Figure 31. Global Antiviral Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 32. Global Antiviral Drugs Sales Market Share by Type (2017-2028)
    Figure 33. Global Antiviral Drugs Revenue Market Share by Type (2017-2028)
    Figure 34. Global Antiviral Drugs Sales Market Share by Application (2017-2028)
    Figure 35. Global Antiviral Drugs Revenue Market Share by Application (2017-2028)
    Figure 36. North America Antiviral Drugs Sales Market Share by Type (2017-2028)
    Figure 37. North America Antiviral Drugs Revenue Market Share by Type (2017-2028)
    Figure 38. North America Antiviral Drugs Sales Market Share by Application (2017-2028)
    Figure 39. North America Antiviral Drugs Revenue Market Share by Application (2017-2028)
    Figure 40. North America Antiviral Drugs Sales Share by Country (2017-2028)
    Figure 41. North America Antiviral Drugs Revenue Share by Country (2017-2028)
    Figure 42. U.S. Antiviral Drugs Revenue (2017-2028) & (US$ Million)
    Figure 43. Canada Antiviral Drugs Revenue (2017-2028) & (US$ Million)
    Figure 44. Europe Antiviral Drugs Sales Market Share by Type (2017-2028)
    Figure 45. Europe Antiviral Drugs Revenue Market Share by Type (2017-2028)
    Figure 46. Europe Antiviral Drugs Sales Market Share by Application (2017-2028)
    Figure 47. Europe Antiviral Drugs Revenue Market Share by Application (2017-2028)
    Figure 48. Europe Antiviral Drugs Sales Share by Country (2017-2028)
    Figure 49. Europe Antiviral Drugs Revenue Share by Country (2017-2028)
    Figure 50. Germany Antiviral Drugs Revenue (2017-2028) & (US$ Million)
    Figure 51. France Antiviral Drugs Revenue (2017-2028) & (US$ Million)
    Figure 52. U.K. Antiviral Drugs Revenue (2017-2028) & (US$ Million)
    Figure 53. Italy Antiviral Drugs Revenue (2017-2028) & (US$ Million)
    Figure 54. Russia Antiviral Drugs Revenue (2017-2028) & (US$ Million)
    Figure 55. Asia Pacific Antiviral Drugs Sales Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Antiviral Drugs Revenue Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Antiviral Drugs Sales Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Antiviral Drugs Revenue Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Antiviral Drugs Sales Share by Region (2017-2028)
    Figure 60. Asia Pacific Antiviral Drugs Revenue Share by Region (2017-2028)
    Figure 61. China Antiviral Drugs Revenue (2017-2028) & (US$ Million)
    Figure 62. Japan Antiviral Drugs Revenue (2017-2028) & (US$ Million)
    Figure 63. South Korea Antiviral Drugs Revenue (2017-2028) & (US$ Million)
    Figure 64. India Antiviral Drugs Revenue (2017-2028) & (US$ Million)
    Figure 65. Australia Antiviral Drugs Revenue (2017-2028) & (US$ Million)
    Figure 66. Taiwan Antiviral Drugs Revenue (2017-2028) & (US$ Million)
    Figure 67. Indonesia Antiviral Drugs Revenue (2017-2028) & (US$ Million)
    Figure 68. Thailand Antiviral Drugs Revenue (2017-2028) & (US$ Million)
    Figure 69. Malaysia Antiviral Drugs Revenue (2017-2028) & (US$ Million)
    Figure 70. Philippines Antiviral Drugs Revenue (2017-2028) & (US$ Million)
    Figure 71. Latin America Antiviral Drugs Sales Market Share by Type (2017-2028)
    Figure 72. Latin America Antiviral Drugs Revenue Market Share by Type (2017-2028)
    Figure 73. Latin America Antiviral Drugs Sales Market Share by Application (2017-2028)
    Figure 74. Latin America Antiviral Drugs Revenue Market Share by Application (2017-2028)
    Figure 75. Latin America Antiviral Drugs Sales Share by Country (2017-2028)
    Figure 76. Latin America Antiviral Drugs Revenue Share by Country (2017-2028)
    Figure 77. Mexico Antiviral Drugs Revenue (2017-2028) & (US$ Million)
    Figure 78. Brazil Antiviral Drugs Revenue (2017-2028) & (US$ Million)
    Figure 79. Argentina Antiviral Drugs Revenue (2017-2028) & (US$ Million)
    Figure 80. Middle East and Africa Antiviral Drugs Sales Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Antiviral Drugs Revenue Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Antiviral Drugs Sales Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Antiviral Drugs Revenue Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Antiviral Drugs Sales Share by Country (2017-2028)
    Figure 85. Middle East and Africa Antiviral Drugs Revenue Share by Country (2017-2028)
    Figure 86. Turkey Antiviral Drugs Revenue (2017-2028) & (US$ Million)
    Figure 87. Saudi Arabia Antiviral Drugs Revenue (2017-2028) & (US$ Million)
    Figure 88. U.A.E Antiviral Drugs Revenue (2017-2028) & (US$ Million)
    Figure 89. Antiviral Drugs Value Chain
    Figure 90. Antiviral Drugs Production Process
    Figure 91. Channels of Distribution
    Figure 92. Distributors Profiles
    Figure 93. Bottom-up and Top-down Approaches for This Report
    Figure 94. Data Triangulation
    Figure 95. Key Executives Interviewed